BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10739385)

  • 1. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
    Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L
    Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates.
    Katona E E; Ajzner E; Tóth K; Kárpáti L; Muszbek L
    J Immunol Methods; 2001 Dec; 258(1-2):127-35. PubMed ID: 11684129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears.
    Orosz ZZ; Katona E; Facskó A; Berta A; Muszbek L
    J Immunol Methods; 2010 Feb; 353(1-2):87-92. PubMed ID: 20079358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form.
    Schroeder V; Vuissoz JM; Caflisch A; Kohler HP
    Thromb Haemost; 2007 Jun; 97(6):890-8. PubMed ID: 17549290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma.
    Oertel K; Hunfeld A; Specker E; Reiff C; Seitz R; Pasternack R; Dodt J
    Anal Biochem; 2007 Aug; 367(2):152-8. PubMed ID: 17582378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome].
    Sugimura D; Fukue H; Arai M; Matsumoto K; Fukutake K
    Rinsho Byori; 1996 Apr; 44(4):355-61. PubMed ID: 8847818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII Deficiency.
    Karimi M; Bereczky Z; Cohan N; Muszbek L
    Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases.
    Thomas V; El Alaoui S; Massignon D; Clément S; Simonet F; Quash G
    Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):171-9. PubMed ID: 16313237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma.
    Kwon MH; Kong DH; Jung SH; Suh IB; Kim YM; Ha KS
    Anal Chem; 2011 Mar; 83(6):2317-23. PubMed ID: 21323342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).
    Souri M; Mokuda S; Inanami H; Osaki T; Takasugi K; Ichinose A
    Thromb Res; 2016 Apr; 140():100-105. PubMed ID: 26938156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
    Tahlan A; Ahluwalia J
    Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
    Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
    Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B protein of factor XIII: differentiation between free B and complexed B.
    Yorifuji H; Anderson K; Lynch GW; Van de Water L; McDonagh J
    Blood; 1988 Nov; 72(5):1645-50. PubMed ID: 3179443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics.
    Nielsen VG; Kirklin JK; Hoogendoorn H; Ellis TC; Holman WL
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):145-50. PubMed ID: 17287631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.